\
&
Contact us
\
&
Contact us
Starts in 1 week from now
LocationOld Library Building of the University of Warsaw
The EUTechSovereignty2025, organized by the Polish Chamber of Commerce for High Technology and University of Warsaw in cooperation with scientific and industrial partners, is an international event that brings together representatives of the high-tech community.
The conference will focus on the EU strategy for Tech Sovereignty and digital and frontier technologies and, in particular, discuss and assess the effectiveness of Horizon Europe in supporting these goals and shape strategies for the next 10th Framework Program. The event will serve as a platform to define concrete steps toward reclaiming the EU’s technological independence and ensuring long-term competitiveness in the global arena.
More info can be found here. You can register here.
EUTechSovereignty2025 is linked to the National Knowledge Valorisation Day conference on 27 May 2025.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
